Vaccine Therapy, Tretinoin, and Cyclophosphamide in Treating Patients With Metastatic Lung Cancer
Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out what effects (good and/or bad) a tumor vaccine used
in combination with two drugs (ATRA and cytoxan) have on the patient and their cancer. We
also want to find out if the vaccine and the drugs can boost the patient's immune system and
how their immune system reacts, both before and after the vaccine treatment.
Phase:
Phase 2
Details
Lead Sponsor:
H. Lee Moffitt Cancer Center and Research Institute
Collaborators:
National Cancer Institute (NCI) National Institutes of Health (NIH)